This Circular shall apply to all individuals vulnerable to COVID-19 as defined under this Circular and to all licensed physicians authorized to prescribe drugs to the aforementioned individuals. The same Circular shall cover all Drugstore/Pharmacy/Botica and similar outlets, but shall not include prescription that requires PDEA S-2 license.
READ MORE–>FDA Circular No. 2020-007
Para sa karagdagang impormasyon sa Circular No. 2020-007, narito ang pahayag ng FDA patungkol dito. BASAHIN —> http://bit.ly/33tbTEQ